Feedback / Questions
BG-1805 - Hedy Group
https://www.globenewswire.com/news-release/2024/05/02/2874092/0/en/Guangzhou-Bio-gene-Technologies-Announces-Initiation-of-Phase-I-Clinical-Trial-for-BG1805-a-CAR-T-Targeting-CLL-1.html
May 2, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next